MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Results 121 - 124 of 124 : « Previous 2 3 4 5 6 7

Recs

0
Member Avatar LuckyGuest (47.39) Submitted: 6/8/2007 11:10:53 AM : Outperform Start Price: $11.52 MNKD Score: -78.50

Unique solutions to medicine delivery.

Report this Post Reply | Reply | Permalink

Recs

0
Member Avatar anylawn (36.90) Submitted: 4/11/2007 4:55:21 PM : Outperform Start Price: $14.67 MNKD Score: -85.50

Great leadership in Alfred Mann.

Report this Post Reply | Reply | Permalink

Recs

0
Member Avatar grochen (52.40) Submitted: 2/27/2007 11:42:06 PM : Underperform Start Price: $16.10 MNKD Score: +89.25

Following eldrehad from his 02/23 pick

Report this Post Reply | Reply | Permalink

Recs

2
Member Avatar pa2818185 (< 20) Submitted: 8/30/2006 9:46:49 PM : Outperform Start Price: $17.82 MNKD Score: -98.02

Superior inahled insulin device and forumulation making this a potential leader in the inhaled insulin market. Would be surprised to see the company bought by another large Pharma once the inhaled insulin market is established.

Report this Post 1 Comment | Reply | Permalink
Results 121 - 124 of 124 : « Previous 2 3 4 5 6 7

Featured Broker Partners


Advertisement